97 related articles for article (PubMed ID: 6136589)
1. Comparison of the effects of nabumetone, a new anti-inflammatory drug, and indomethacin on arachidonic acid-induced hypotension in the rat.
Hamilton TC; Longman SD
J Pharm Pharmacol; 1983 Jul; 35(7):458-9. PubMed ID: 6136589
[No Abstract] [Full Text] [Related]
2. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
Boyle EA; Freeman PC; Mangan FR; Thomson MJ
J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
4. The antihypertensive action of arachidonic acid in the spontaneous hypertensive rat and its antagonism by anti-inflammatory agents.
Cohen M; Sztokalo J; Hinsch E
Life Sci; 1973 Aug; 13(4):317-25. PubMed ID: 4752485
[No Abstract] [Full Text] [Related]
5. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
[TBL] [Abstract][Full Text] [Related]
7. Different effects of indomethacin and nabumetone on prostaglandin-mediated gastric responses to central vagal activation in rats.
Cardin S; Soll AH; Taché Y
J Pharmacol Exp Ther; 1995 Nov; 275(2):667-73. PubMed ID: 7473153
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
[TBL] [Abstract][Full Text] [Related]
9. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
Melarange R; Spangler R; Hoult JR
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
Dandona P; Jeremy JY
Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats.
bin Long I; Singh HJ; Rao GJ
J Pharmacol Sci; 2005 Nov; 99(3):272-6. PubMed ID: 16293937
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of prostaglandin synthetase in vivo by nonsteroidal anti-inflammatory agents.
Mathur PP; Riley RL; Richardson CP; Reavey-Cantwell NH
Agents Actions; 1977 Jul; 7(2):283-8. PubMed ID: 409117
[TBL] [Abstract][Full Text] [Related]
13. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
[TBL] [Abstract][Full Text] [Related]
14. Reduced hypotensive action of arachidonic acid in the spontaneously hypertensive rat.
Lukacsko P; Messina EJ; Kaley G
Hypertension; 1980; 2(5):657-63. PubMed ID: 6998871
[No Abstract] [Full Text] [Related]
15. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen.
Nunn B; Chamberlain PD
J Pharm Pharmacol; 1982 Sep; 34(9):576-9. PubMed ID: 6127382
[TBL] [Abstract][Full Text] [Related]
16. The effect of nabumetone and indomethacin on gastric mucosal function.
Shorrock CJ; Rees WD
J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
[No Abstract] [Full Text] [Related]
17. Correlation between inhibition by anti-inflammatory substances, of arachidonic acid-induced hypotension and of prostaglandin biosynthesis in vitro.
Damas J; Deby C
Biochem Pharmacol; 1976 Apr; 25(8):983-5. PubMed ID: 1267844
[No Abstract] [Full Text] [Related]
18. Chronic nicotine treatment enhances the depressor responses to arachidonic acid in the rat.
Hui SC; Ogle CW
Pharmacology; 1991; 42(5):257-61. PubMed ID: 1908582
[TBL] [Abstract][Full Text] [Related]
19. Comparison of indomethacin and the prodrugs, fenbufen and nabumetone, on human gastric morphology and blood flow.
Shorrock CJ; Rees WD
J Rheumatol Suppl; 1992 Nov; 36():89-91. PubMed ID: 1474544
[No Abstract] [Full Text] [Related]
20. Effects of the prodrug nabumetone, and its active metabolite, 6-MNA, on human and rat gastric mucosal prostanoids and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Drugs; 1990; 40 Suppl 5():53-6. PubMed ID: 2081494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
